Globus Medical Inc (GMED)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 92,485 | 68,612 | 73,831 | 60,784 | 54,458 |
| Depreciation Amortization | 24,434 | 21,755 | 18,108 | 16,949 | 15,196 |
| Income taxes - deferred | -4,379 | -14,858 | -6,079 | 2,057 | 1,999 |
| Accounts receivable | -12,667 | -9,612 | -6,886 | -4,672 | -6,560 |
| Accounts payable and accrued liabilities | 7,331 | 1,940 | 4,426 | -2,051 | 2,720 |
| Other Working Capital | -42,220 | 8,636 | -20,458 | -17,258 | -10,661 |
| Other Operating Activity | 14,188 | 16,998 | 13,577 | 20,601 | 14,136 |
| Operating Cash Flow | $79,172 | $93,471 | $76,519 | $76,410 | $71,288 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 212,304 | 54,197 | N/A | N/A | 300 |
| PPE Investments | -24,754 | -23,680 | -24,684 | -22,487 | -12,303 |
| Net Acquisitions | -36,128 | -16,775 | -6,031 | -7,500 | N/A |
| Purchase Of Investment | -251,422 | -240,892 | N/A | N/A | N/A |
| Investing Cash Flow | $-100,000 | $-227,150 | $-30,715 | $-29,987 | $-12,003 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | -5,253 | -340 |
| Common Stock Issued | 9,738 | 7,555 | 22,464 | 886 | 1,321 |
| Common Stock Repurchased | N/A | N/A | N/A | -10,021 | N/A |
| Other Financing Activity | 3,208 | 3,456 | 1,561 | -346 | 787 |
| Financing Cash Flow | $12,946 | $11,011 | $24,025 | $-14,734 | $1,768 |
| Exchange Rate Effect | 185 | 230 | -97 | -722 | -2 |
| Beginning Cash Position | 89,962 | 212,400 | 142,668 | 111,701 | 50,650 |
| End Cash Position | 82,265 | 89,962 | 212,400 | 142,668 | 111,701 |
| Net Cash Flow | $-7,697 | $-122,438 | $69,732 | $30,967 | $61,051 |
| Free Cash Flow | |||||
| Operating Cash Flow | 79,172 | 93,471 | 76,519 | 76,410 | 71,288 |
| Capital Expenditure | -24,754 | -23,680 | -24,684 | -22,487 | -12,303 |
| Free Cash Flow | 54,418 | 69,791 | 51,835 | 53,923 | 58,985 |